Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Biochimie ; 219: 96-109, 2024 Apr.
Article de Anglais | MEDLINE | ID: mdl-37541568

RÉSUMÉ

Melatonin is a pleiotropic neurohormone found in different animal, plant, and microorganism species. It is a product resulting from tryptophan metabolism in the pineal gland and is widely known for its ability to synchronize the circadian rhythm to antitumor functions in different types of cancers. The molecular mechanisms responsible for its immunomodulatory, antioxidant and cytoprotective effects involve binding to high-affinity G protein-coupled receptors and interactions with intracellular targets that modulate signal transduction pathways. In vitro and in vivo studies have reported the therapeutic potential of melatonin in different infectious and parasitic diseases. In this review, the protective and pathophysiological roles of melatonin in fighting protozoan and helminth infections and the possible mechanisms involved against these stressors will be discussed.


Sujet(s)
Helminthes , Mélatonine , Maladies parasitaires , Glande pinéale , Animaux , Mélatonine/métabolisme , Mélatonine/usage thérapeutique , Glande pinéale/métabolisme , Antioxydants/pharmacologie , Maladies parasitaires/traitement médicamenteux , Helminthes/métabolisme , Rythme circadien/physiologie
2.
Am J Trop Med Hyg ; 103(2): 909-916, 2020 08.
Article de Anglais | MEDLINE | ID: mdl-32602430

RÉSUMÉ

The aims of this study were to describe a smartphone app aimed at healthcare professionals who work in areas endemic for visceral and tegumentary leishmaniases, and to report the user's perception of the app in these areas. The software, called LeishCare®, has the following features: data registration, image filter to record the evolution of skin lesions using photos, calculation of a score set to identify the risk of death from visceral leishmaniasis, and guides to the diseases. LeishCare® was made available to healthcare professionals in endemic municipalities in Brazil, and the perception of potential users was evaluated at baseline and after 6 and 12 months. In the first meeting, 96 (94.1%) of the 102 professionals who knew the app reported positive expectations for its use. The installation of LeishCare® on the individual device and the evaluation of user perception were completed at 6 months with 16 users and at 12 months with 20 users. More than 90% of the professionals evaluated in both assessments found the information of the app useful. The features related to the calculation of visceral leishmaniasis severity score, and the guides to leishmaniases were the most frequently accessed. Users reported competence gain attributed to the app for all items evaluated. In conclusion, LeishCare® was found to be a promising tool to help healthcare professionals in endemic areas with leishmaniasis management.


Sujet(s)
Leishmaniose cutanée/thérapie , Leishmaniose viscérale/thérapie , Applications mobiles , Ordiphone , Attitude du personnel soignant , Brésil , Comportement du consommateur , Prise en charge de la maladie , Diagnostic précoce , Intervention médicale précoce , Maladies endémiques , Humains , Diffusion de l'information , Leishmaniose cutanée/diagnostic , Leishmaniose viscérale/diagnostic , Photographie (méthode) , Appréciation des risques , Logiciel
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...